AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
IPO Year: 2018
Exchange: NASDAQ
Website: adapthealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/8/2024 | $14.50 → $8.00 | Buy → Hold | Jefferies |
| 11/8/2023 | $9.50 → $6.50 | Neutral → Underperform | BofA Securities |
| 5/10/2023 | $28.00 → $11.30 | Buy → Hold | Deutsche Bank |
| 5/10/2023 | $18.00 → $11.00 | Buy → Hold | Stifel |
| 5/9/2023 | $21.00 → $12.00 | Buy → Neutral | BofA Securities |
| 3/8/2022 | $31.00 → $26.00 | Outperform | RBC Capital |
| 3/2/2022 | $32.00 → $24.00 | Outperform | SVB Leerink |
| 2/18/2022 | $35.00 → $32.00 | Outperform | SVB Leerink |
| 11/5/2021 | $30.00 → $35.00 | Outperform | SVB Leerink |
| 9/27/2021 | $30.00 | Outperform | SVB Leerink |